From Yahoo Finance: 2025-04-12 09:05:00

In a recent article, Johnson & Johnson (NYSE:JNJ) is compared to other cheap NYSE stocks. On CNBC’s ‘Squawk Box’, JPMorgan’s Jack Caffrey discussed market trends, emphasizing diversified portfolios and the importance of ‘time in the market’ over ‘timing the market’. The MAG7 drives market trends, with investors exploring AI-related trades. Stimulus measures in Europe are shifting from monetary to fiscal policies.

Johnson & Johnson (NYSE:JNJ) has a forward P/E ratio of 14.24 and 98 hedge fund holders. The company saw a 7% increase in operational sales in 2024, excluding the impact of COVID-19. JNJ announced plans to invest over $55 billion in US manufacturing, R&D, and technology. UBS reaffirmed a Buy rating and $180 price target on the stock.

JNJ ranks 7th on the list of cheap NYSE stocks according to hedge funds. While JNJ shows growth potential, AI stocks are seen as promising for high returns in a shorter time frame. An AI stock has shown gains in 2025, while popular AI stocks have declined. Check out the report on the cheapest AI stock for more information.

Read more: Is Johnson & Johnson (NYSE:JNJ) a Cheap NYSE Stock to Invest in According to Hedge Funds?